Artificial intelligence for liver diseases: The urgency of collaboration

We have read with interest the paper by Balsano et al [ [1] Balsano C. Burra P. Duvoux C. Alisi A. Piscaglia F. Gerussi A. Special interest group (SIG) artificial intelligence and liver disease; Italian association for the study of liver (AISF). Artif Intellig liver: Opportun barriers. Dig Liver Dis. 2023; 55 (Nov): 1455-1461https://doi.org/10.1016/j.dld.2023.08.048 Abstract Full Text Full Text PDF Scopus (0) Google Scholar ]. about opportunities and barriers of Artificial Intelligence in hepatology and liver surgery apllications. While this review contributes to the existing knowledge, we would like to raise some concerns that warrant further consideration. Artificial Intelligence and liver: Opportunities and barriersDigestive and Liver DiseaseVol. 55Issue 11PreviewArtificial Intelligence (AI) has recently been shown as an excellent tool for the study of the liver; however, many obstacles still have to be overcome for the digitalization of real-world hepatology. The authors present an overview of the current state of the art on the use of innovative technologies in different areas (big data, translational hepatology, imaging, and transplant setting). In clinical practice, physicians must integrate a vast array of data modalities (medical history, clinical data, laboratory tests, imaging, and pathology slides) to achieve a diagnostic or therapeutic decision. Full-Text PDF Open Access